Adverse events in apheresis: An update of the WAA registry data (Q26771588)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

title

Adverse events in apheresis: An update of the WAA registry data (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

author name string

M Mörtzell Henriksson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

E Newman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

V Witt

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

K Derfler

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

G Leitner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

S Eloot

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

A Dhondt

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

D Deeren

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

G Rock

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

J Ptak

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

M Lanska

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Z Gasova

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

R Hrdlickova

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

W Ramlow

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

H Prophet

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

G Liumbruno

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

E Mori

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

A Griskevicius

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

J Audzijoniene

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

H Vrielink

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

S Rombout

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

A Aandahl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

A Sikole

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

J Tomaz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

K Lalic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

S Mazic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

V Strineholm

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

B Brink

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

G Berlin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

J Dykes

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

F Toss

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

C G Axelsson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

B Stegmayr

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

T Nilsson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

R Norda

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

F Knutson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

B Ramsauer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

A Wahlström

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

language of work or name

English

0 references

publication date

8 January 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

Transfusion and Apheresis Science

5 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

page(s)

2-15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26776481%20AND%20SRC:MED&resulttype=core&format=json

Recovery from Goodpasture's syndrome after immunosuppressive treatment and plasmapheresis

5 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

A survey of blood purification techniques.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

The new approach to assignment of ASFA categories--introduction to the fourth special issue: clinical applications of therapeutic apheresis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

The Canadian apheresis registry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

Plasma exchange for kidney disease: what is the best evidence?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

14 years of therapeutic plasma exchange in France.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

Plasma exchange in France: Epidemiology 2001.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

What are the indications for plasma exchanges in autoimmune diseases?: The registry of the Société Française d'Hémaphérèse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

The Italian SIdEM registry for apheresis: an overview of the 2005 statistics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

The Italian Registry of Pediatric Therapeutic Apheresis: a report on activity during 2005.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

The Italian Registry of Therapeutic Apheresis: granulocyte-monocyte apheresis in the treatment of inflammatory bowel disease. A multicentric study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

Apheresis registry in Sweden: scope, techniques and indications for treatment. A report from the Swedish apheresis study group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

Recognition of intercenter differences may help develop best practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

Establishment of a national on-line registry for apheresis in Korea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

WAA apheresis registry in the Czech Republic: two centers experience.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

Impact of the German Lipoprotein Apheresis Registry (DLAR) on therapeutic options to reduce increased Lp(a) levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

First data from the German Lipoprotein Apheresis Registry (GLAR).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

RheoNet registry analysis of rheopheresis for microcirculatory disorders with a focus on age-related macular degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

World apheresis registry 2003-2007 data.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

World apheresis registry data from 2003 to 2007, the pediatric and adolescent side of the registry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

Apheresis technologies and clinical applications: the 2002 international apheresis registry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

Apheresis technologies and clinical applications: the 2005 International Apheresis Registry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

Apheresis technologies and clinical applications: the 2007 International Apheresis Registry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. Members of the Canadian Apheresis Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

Pentastarch instead of albumin as replacement fluid for therapeutic plasma exchange. The Canadian Apheresis Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

The Canadian experience using plasma exchange for immune thrombocytopenic purpura. Canadian Apheresis Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

Plasmapheresis in acute multiple sclerosis: Rationale and results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

Plasma exchange when myeloma presents as acute renal failure: a randomized, controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

Therapeutic plasma exchange: complications and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

Hypocalcemic toxicity and atypical reactions in therapeutic plasma exchange

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

Controlled study of citrate effects and response to i.v. calcium administration during allogeneic peripheral blood progenitor cell donation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

Unexpected effects of donor gender on the storage of liquid plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

Complement activation products in liquid stored plasma and C3a kinetics after transfusion of autologous plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

Complement activation in plasma exchange by single filtration and centrifugation and in cascade filtration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

Therapeutic apheresis in Sweden: update of epidemiology and adverse events.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

Prevention of citrate reactions during therapeutic plasma exchange by constant infusion of calcium gluconate with the return fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

Safety of large-volume leukapheresis for collection of peripheral blood progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

Clinically relevant hypokalaemia, hypocalcaemia, and loss of hemoglobin and platelets during stem cell apheresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

Randomized placebo‐controlled study of oral calcium carbonate supplementation in plateletpheresis: II. Metabolic effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

Comprehensive analysis of citrate effects during plateletpheresis in normal donors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

Citrate pharmacokinetics and calcium levels during high-flux dialysis with regional citrate anticoagulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

What's happening: an overview of potential adverse reactions associated with apheresis technology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

World apheresis registry report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

Randomized placebo‐controlled study of oral calcium carbonate administration in plateletpheresis: I. Associations with donor symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

QTc prolongation in apheresis platelet donors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003

New insight in impaired binding capacity for albumin in uraemic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2016.01.003